Search Results

170 articles with title/keywords/abstract containing controlled-release formulation

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Display per page 

Optimization of physicochemical parameters influencing the fabrication of protein-loaded chitosan nanoparticles

Authors: Vandana, Mallaredy; Sahoo, Sanjeeb K

Source: Nanomedicine, Volume 4, Number 7, October 2009 , pp. 773-785(13)

Publisher: Future Medicine

Women with Pain due to Osteoarthritis: The Efficacy and Safety of a Once-Daily Formulation of Tramadol

Authors: Kean, Walter F.; Bouchard, Sylvie; Roderich Gossen, E.

Source: Pain Medicine, Volume 10, Number 6, September 2009 , pp. 1001-1011(11)

Publisher: Blackwell Publishing

Clinical efficacy and safety of a once-daily formulation of carbimazole in cats with hyperthyroidism

Authors: Frénais, R.; Rosenberg, D.; Burgaud, S.; Horspool, L. J. I.

Source: The Journal of Small Animal Practice, Volume 50, Number 10, October 2009 , pp. 510-515(6)

Publisher: Blackwell Publishing

Formulation of intelligent tablets with an antacid effect

Authors: Bajdik, János; Korbely, Anita; Pintye-Hódi, Klára

Source: Pharmaceutical Development and Technology, Volume 14, Number 5, October 2009 , pp. 471-475(5)

Publisher: Informa Healthcare

Formulation affecting alachlor efficacy and persistence in sandy soils

Authors: Sopeña, Fátima; Maqueda, Celia; Morillo, Esmeralda

Source: Pest Management Science, Volume 65, Number 7, July 2009 , pp. 761-768(8)

Publisher: John Wiley & Sons, Ltd.

Development of a Budget-Impact Model to Quantify Potential Cost Savings from Prescription Opioids Designed to Deter Abuse or Ease of Extraction

Authors: White, Alan G.; Birnbaum, Howard G.; Rothman, Dov B.; Katz, Nathaniel

Source: Applied Health Economics and Health Policy, Volume 7, Number 1, 1 March 2009 , pp. 61-70(10)

Publisher: Adis International

Role of carvedilol controlled-release in cardiovascular disease

Author: Fonarow, Gregg C

Source: Expert Review of Cardiovascular Therapy, Volume 7, Number 5, May 2009 , pp. 483-498(16)

Publisher: Expert Reviews

A BIOAVAILABILITY/BIOEQUIVALENCE AND PHARMACOKINETIC STUDY OF TWO ORAL DOSES OF TORASEMIDE (5 AND 10 mg): PROLONGED-RELEASE VERSUS THE CONVENTIONAL FORMULATION

Authors: Barbanoj, MJ; Ballester, MR; Antonijoan, RM; Puntes, M; Gropper, S; Santos, B; Albet, C; Guglietta, A

Source: Clinical and Experimental Pharmacology and Physiology, Volume 36, Numbers 5-6, May/June 2009 , pp. 469-477(9)

Publisher: Blackwell Publishing

Pharmacokinetics of a controlled-release liposome-encapsulated hydromorphone administered to healthy dogs

Authors: SMITH, L. J.; KuKANICH, B.; HOGAN, B. K.; BROWN, C.; HEATH, T. D.; KRUGNER-HIGBY, L. A.

Source: Journal of Veterinary Pharmacology & Therapeutics, Volume 31, Number 5, October 2008 , pp. 415-422(8)

Publisher: Blackwell Publishing

Advancing Forest Cover Development on a High-Elevation Sierra Nevada Mine Site with Nutritional Amendments

Author: Walker, Roger F.

Source: Restoration Ecology, Volume 16, Number 3, September 2008 , pp. 486-494(9)

Publisher: Blackwell Publishing

Controlled-Release Carvedilol

Authors: Carter, Natalie J.; Keating, Gillian M.

Source: American Journal of Cardiovascular Drugs, Volume 8, Number 4, 2008 , pp. 271-282(12)

Publisher: Adis International

Formulation and Evaluation of Chitosan-Gellan Based Methotrexate Implants

Authors: Kumar, S. Chetan; Satish, C. S.; Shivakumar, H. G.

Source: Journal of Macromolecular Science, Part A: Pure and Applied Chemistry, Volume 45, Number 8, August 2008 , pp. 643-649(7)

Publisher: Taylor and Francis Ltd

Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibit the growth of non-muscle-invasive bladder cancer

Authors: Hadaschik, Boris A.; Jackson, John; Fazli, Ladan; Zoubeidi, Amina; Burt, Helen M.; Gleave, Martin E.; So, Alan I.

Source: BJU International, Volume 102, Number 5, September 2008 , pp. 610-616(7)

Publisher: Blackwell Publishing

Pharmacokinetics of controlled-release carbimazole tablets support once daily dosing in cats

Authors: FRÉNAIS, R.; BURGAUD, S.; HORSPOOL, L. J. I.

Source: Journal of Veterinary Pharmacology & Therapeutics, Volume 31, Number 3, June 2008 , pp. 213-219(7)

Publisher: Blackwell Publishing

Pharmacokinetic profile of a 24-hour controlled-release OROS formulation of hydromorphone in the presence of alcohol

Authors: Sathyan, G.; Sivakumar, K.; Thipphawong, J.

Source: Current Medical Research and Opinion, Volume 24, Number 1, January 2008 , pp. 297-305(9)

Publisher: Informa Healthcare

Controlled-release formulations of cyromazine-lignin matrix coated with ethylcellulose

Authors: Fernández-Pérez, M.; Villafranca-Sánchez, M.; Flores-Céspedes, F.

Source: Journal of Environmental Science and Health, Part B, Volume 42, Number 7, September 2007 , pp. 863-868(6)

Publisher: Taylor and Francis Ltd

Microcapsule-gel formulation of promethazine HCl for controlled nasal delivery: A motion sickness medication

Authors: McDonough, J. A.; Persyn, J. T.; Nino, J. A.; Dixon, H.; Boland, E. J.; Wang, Z.; Putcha, L.

Source: Journal of Microencapsulation, Volume 24, Number 2, 2007 , pp. 109-116(8)

Publisher: Informa Healthcare

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A